Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Condition(s):HER2/Neu Negative; Invasive Breast Carcinoma; Postmenopausal; Stage 0 Breast Cancer; Stage IA Breast CancerLast Updated:December 27, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):HER2/Neu Negative; Invasive Breast Carcinoma; Postmenopausal; Stage 0 Breast Cancer; Stage IA Breast CancerLast Updated:December 27, 2018Withdrawn
Condition(s):Breast CancerLast Updated:February 8, 2024Recruiting
Condition(s):Neuromuscular Monitoring; Sugammadex EffectLast Updated:August 7, 2018Completed
Condition(s):Breast Cancer Stage ILast Updated:March 22, 2024Recruiting
Condition(s):Breast CancerLast Updated:March 22, 2024Recruiting
Condition(s):Breast CancerLast Updated:July 2, 2017Unknown status
Condition(s):Breast Cancer OrganoidsLast Updated:April 24, 2019Unknown status
Condition(s):Urothelial Carcinoma; Bladder Cancer; Urinary Bladder NeoplasmsLast Updated:November 6, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.